Mycobacterium tuberculosis possesses a large number of genes of unknown or predicted
function, undermining fundamental understanding of pathogenicity and drug susceptibility …

Intracellular pathogens including Mycobacterium tuberculosis (Mtb) have evolved with
strategies to uptake amino acids from host cells to fulfil their metabolic requirements …

According to the latest World Health Organization (WHO) report, an estimated 10.6 million
people were diagnosed with tuberculosis (TB) in 2022, and 1.30 million died. A major …

The increasing emergence of multidrug-resistant pathogens and development of
biopreservatives in food industries has increased the demand of novel and safe …

BACKGROUND Campylobacter jejuni (C. jejuni), a widely distributed global foodborne
pathogen, primarily linked with contaminated chicken meat, poses a significant health risk …

Mycobacterium tuberculosis (Mtb), the causative agent of human tuberculosis (TB), employs
ten enzymes including imidazoleglycerol‐phosphate dehydratase (IGPD) for de novo …

Current Tuberculosis treatment is long and expensive, faces the increasing burden of
MDR/XDR strains and lack of effective treatment against latent form, resulting in an urgent …

Nitrogen metabolism of M. tuberculosis is critical for its survival in infected host cells. M.
tuberculosis has evolved sophisticated strategies to switch between de novo synthesis and …

The intracellular pathogen Mycobacterium tuberculosis can survive and replicate within host
macrophages. Among various immunomodulatory substances, macrophages also produce …

Acanthamoeba is normally free-living, but sometimes facultative and occasionally
opportunistic parasites. Current therapies are, by necessity, arduous and yet poorly effective …